Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2019-08-26 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 普莱柯生物工程股份有限公司 regarding the completion of a business registration change, specifically the completion of share repurchase and cancellation of restricted shares, and the update of company registration details such as registered capital and legal representative. It does not contain financial statements or detailed financial data. The document is relatively short (901 characters) and serves as a formal notification of corporate changes rather than a full report. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-08-26 Chinese
关于召开2019年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2019 first extraordinary general meeting of shareholders for 普莱柯生物工程股份有限公司. It includes details about the meeting date, voting methods, agenda items, and instructions for shareholders to participate and vote. It does not contain financial statements, audit information, or detailed management discussion. It is a formal announcement to shareholders about the meeting logistics and agenda, not the meeting minutes or voting results. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2019-08-25 Chinese
独立董事关于第三届董事会第十九次会议的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on a specific board meeting agenda item regarding a related party transaction and waiver of preemptive rights. It references the company's board meeting and legal compliance but does not contain financial statements or detailed financial data. It is a formal opinion related to board/management matters rather than a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on management-level decision commentary, not a report or announcement of voting results.
2019-08-25 Chinese
关于放弃参股公司增资优先认购权暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding its decision to waive its preemptive rights to subscribe for additional capital in an associated company, which constitutes a related party transaction. It details the transaction overview, related parties, financial data of the investee, pricing basis, and the approval process including board and independent directors' opinions. The document is a formal disclosure of a corporate transaction involving capital increase and related party dealings, not a financial report, earnings release, or management discussion. It is not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it concerns changes in capital structure and financing activities related to investment and capital increase.
2019-08-25 Chinese
第三届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of 普莱柯生物工程股份有限公司, including approval of proposals and notification of a forthcoming shareholder meeting. It details the meeting date, attendance, voting results, and references further information on the stock exchange website. There is no financial data, audit information, or report content. The document is clearly about board decisions and management matters, specifically board meeting resolutions and related governance actions. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear keywords like "董事会会议审议情况" (board meeting resolutions) and voting results at the board level.
2019-08-25 Chinese
第三届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement from the Supervisory Board of a company regarding the resolutions passed in their meeting. It includes approval of the 2019 half-year report and related financial and accounting matters. The document is an announcement of the meeting's resolutions and does not contain the full half-year report itself, but rather confirms the approval and compliance of the report. The document length is short (980 characters), and it serves as a formal disclosure of meeting decisions rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the supervisory board meeting and report approval.
2019-08-21 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.